Huntingtin and huntingtin-associated protein 1 influence neuronal calcium signaling mediated by inositol-(1,4,5) triphosphate receptor type 1

Neuron

Volumn 39, Issue 2, 2003, Pages 227-239

  Tang, Tie Shan ^a   Tu, Huiping ^a   Chan, Edmond Y W ^c   Maximov, Anton ^b   Wang, Zhengnan ^a   Wellington, Cheryl L ^d   Hayden, Michael R ^c   Bezprozvanny, Ilya ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CASPASE; HUNTINGTIN; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; METABOTROPIC RECEPTOR AGONIST;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM SIGNALING; CALCIUM TRANSPORT; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; EMBRYO; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUNTINGTON CHOREA; LIPID BILAYER; MOLECULAR BIOLOGY; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ISOLATION; PROTEIN PROTEIN INTERACTION; RAT; STRIATE CORTEX; TWO HYBRID SYSTEM;

EID: 0041963057     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-6273(03)00366-0     Document Type: Article

References (63)

1. Berridge M.J. Neuronal calcium signaling. Neuron. 21:1998;13-26.
2. Bertaux F., Sharp A.H., Ross C.A., Lehrach H., Bates G.P., Wanker E. HAP1-huntingtin interactions do not contribute to the molecular pathology in Huntington's disease transgenic mice. FEBS Lett. 426:1998;229-232.
3. 3- and calcium-gated channels from endoplasmic reticulum of cerebellum. Nature. 351:1991;751-754.
4. Calabresi P., Centonze D., Pisani A., Bernardi G. Metabotropic glutamate receptors and cell-type-specific vulnerability in the striatum. implication for ischemia and Huntington's disease Exp. Neurol. 158:1999;97-108.
5. Chan E.Y., Nasir J., Gutekunst C.A., Coleman S., Maclean A., Maas A., Metzler M., Gertsenstein M., Ross C.A., Nagy A., Hayden M.R. Targeted disruption of Huntingtin-associated protein-1 (Hap1) results in postnatal death due to depressed feeding behavior. Hum. Mol. Genet. 11:2002;945-959.
6. Chen N., Luo T., Wellington C., Metzler M., McCutcheon K., Hayden M.R., Raymond L.A. Subtype-specific enhancement of NMDA receptor currents by mutant huntingtin. J. Neurochem. 72:1999;1890-1898.
7. Chesselet M.F., Mercugliano M., Soghomonian J.J., Salin P., Qin Y., Gonzales C. Regulation of glutamic acid decarboxylase gene expression in efferent neurons of the basal ganglia. Prog. Brain Res. 99:1993;143-154.
8. Colomer V., Engelender S., Sharp A.H., Duan K., Cooper J.K., Lanahan A., Lyford G., Worley P., Ross C.A. Huntingtin-associated protein 1 (HAP1) binds to a Trio-like polypeptide, with a rac1 guanine nucleotide exchange factor domain. Hum. Mol. Genet. 6:1997;1519-1525.
9. Cooper J.K., Schilling G., Peters M.F., Herring W.J., Sharp A.H., Kaminsky Z., Masone J., Khan F.A., Delanoy M., Borchelt D.R.et al. Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture. Hum. Mol. Genet. 7:1998;783-790.
10. Cross A.J., Crow T.J., Johnson J.A., Dawson J.M., Peters T.J. Loss of endoplasmic reticulum-associated enzymes in affected brain regions in Huntington's disease and Alzheimer-type dementia. J. Neurol. Sci. 71:1985;137-143.
11. Engelender S., Sharp A.H., Colomer V., Tokito M.K., Lanahan A., Worley P., Holzbaur E.L., Ross C.A. Huntingtin-associated protein 1 (HAP1) interacts with the p150Glued subunit of dynactin. Hum. Mol. Genet. 6:1997;2205-2212.
12. Furuichi T., Kohda K., Miyawaki A., Mikoshiba K. Intracellular channels. Curr. Opin. Neurobiol. 4:1994;294-303.
13. Gerfen C.R. The neostriatal mosaic. multiple levels of compartmental organization Trends Neurosci. 15:1992;133-139.
14. Goffredo D., Rigamonti D., Tartari M., De Micheli A., Verderio C., Matteoli M., Zuccato C., Cattaneo E. Calcium-dependent cleavage of endogenous wild-type huntingtin in primary cortical neurons. J. Biol. Chem. 277:2002;39594-39598.
15. Gusella J.F., MacDonald M.E. Huntingtin. a single bait hooks many species Curr. Opin. Neurobiol. 8:1998;425-430.
16. Gutekunst C.A., Li S.H., Yi H., Ferrante R.J., Li X.J., Hersch S.M. The cellular and subcellular localization of huntingtin-associated protein 1 (HAP1). comparison with huntingtin in rat and human J. Neurosci. 18:1998;7674-7686.
17. Hackam A.S., Singaraja R., Wellington C.L., Metzler M., McCutcheon K., Zhang T., Kalchman M., Hayden M.R. The influence of huntingtin protein size on nuclear localization and cellular toxicity. J. Cell Biol. 141:1998;1097-1105.
18. HDCRG A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell. 72:1993;971-983.
19. Hodgson J.G., Agopyan N., Gutekunst C.A., Leavitt B.R., LePiane F., Singaraja R., Smith D.J., Bissada N., McCutcheon K., Nasir J.et al. A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration. Neuron. 23:1999;181-192.
20. Juin P., Pelletier M., Oliver L., Tremblais K., Gregoire M., Meflah K., Vallette F.M. Induction of a caspase-3-like activity by calcium in normal cytosolic extracts triggers nuclear apoptosis in a cell-free system. J. Biol. Chem. 273:1998;17559-17564.
21. Kalchman M.A., Koide H.B., McCutcheon K., Graham R.K., Nichol K., Nishiyama K., Kazemi-Esfarjani P., Lynn F.C., Wellington C., Metzler M.et al. HIP1, a human homologue of S. cerevisiae Sla2p, interacts with membrane-associated huntingtin in the brain. Nat. Genet. 16:1997;44-53.
22. Kaznacheyeva E., Lupu V.D., Bezprozvanny I. Single-channel properties of inositol (1,4,5)-trisphosphate receptor heterologously expressed in HEK-293 cells. J. Gen. Physiol. 111:1998;847-856.
23. Kerner J.A., Standaert D.G., Penney J.B. Jr., Young A.B., Landwehrmeyer G.B. Expression of group one metabotropic glutamate receptor subunit mRNAs in neurochemically identified neurons in the rat neostriatum, neocortex, and hippocampus. Brain Res. Mol. Brain Res. 48:1997;259-269.
24. Kim Y.J., Yi Y., Sapp E., Wang Y., Cuiffo B., Kegel K.B., Qin Z.H., Aronin N., DiFiglia M. Caspase 3-cleaved N-terminal fragments of wild-type and mutant huntingtin are present in normal and Huntington's disease brains, associate with membranes, and undergo calpain-dependent proteolysis. Proc. Natl. Acad. Sci. USA. 98:2001;12784-12789.
25. Korkotian E., Schwarz A., Pelled D., Schwarzmann G., Segal M., Futerman A.H. Elevation of intracellular glucosylceramide levels results in an increase in endoplasmic reticulum density and in functional calcium stores in cultured neurons. J. Biol. Chem. 274:1999;21673-21678.
26. Kuppenbender K.D., Albers D.S., Iadarola M.J., Landwehrmeyer G.B., Standaert D.G. Localization of alternatively spliced NMDAR1 glutamate receptor isoforms in rat striatal neurons. J. Comp. Neurol. 415:1999;204-217.
27. Landwehrmeyer G.B., Standaert D.G., Testa C.M., Penney J.B. Jr., Young A.B. NMDA receptor subunit mRNA expression by projection neurons and interneurons in rat striatum. J. Neurosci. 15:1995;5297-5307.
28. Li X.J., Li S.H., Sharp A.H., Nucifora F.C. Jr., Schilling G., Lanahan A., Worley P., Snyder S.H., Ross C.A. A huntingtin-associated protein enriched in brain with implications for pathology. Nature. 378:1995;398-402.
29. Li S.H., Gutekunst C.A., Hersch S.M., Li X.J. Interaction of huntingtin-associated protein with dynactin P150Glued. J. Neurosci. 18:1998;1261-1269. a.
30. Li S.H., Hosseini S.H., Gutekunst C.A., Hersch S.M., Ferrante R.J., Li X.J. A human HAP1 homologue. Cloning, expression, and interaction with huntingtin. J. Biol. Chem. 273:1998;19220-19227. b.
31. Li Y., Chin L.S., Levey A.I., Li L. Huntingtin-associated protein 1 interacts with hepatocyte growth factor-regulated tyrosine kinase substrate and functions in endosomal trafficking. J. Biol. Chem. 277:2002;28212-28221.
32. Mao L., Wang J.Q. Upregulation of preprodynorphin and preproenkephalin mRNA expression by selective activation of group I metabotropic glutamate receptors in characterized primary cultures of rat striatal neurons. Brain Res. Mol. Brain Res. 86:2001;125-137.
33. Mao L., Wang J.Q. Glutamate cascade to cAMP response element-binding protein phosphorylation in cultured striatal neurons through calcium-coupled group I metabotropic glutamate receptors. Mol. Pharmacol. 62:2002;473-484.
34. Matsumoto M., Nakagawa T., Inoue T., Nagata E., Tanaka K., Takano H., Minowa O., Kuno J., Sakakibara S., Yamada M.et al. Ataxia and epileptic seizures in mice lacking type 1 inositol 1,4,5-trisphosphate receptor. Nature. 379:1996;168-171.
35. Mattson M.P. Apoptosis in neurodegenerative disorders. Nat. Rev. Mol. Cell Biol. 1:2000;120-129.
36. Mattson M.P., Chan S.L. Dysregulation of cellular calcium homeostasis in Alzheimer's disease. bad genes and bad habits J. Mol. Neurosci. 17:2001;205-224.
37. Maximov A., Bezprozvanny I. Synaptic targeting of N-type calcium channels in hippocampal neurons. J. Neurosci. 22:2002;6939-6952.
38. Maximov A., Tang T.-S., Bezprozvanny I. Association of the type 1 inositol (1,4,5)-trisphosphate receptor with 4.1N protein in neurons. Mol. Cell. Neurosci. 22:2003;271-283.
39. Menalled L.B., Chesselet M.F. Mouse models of Huntington's disease. Trends Pharmacol. Sci. 23:2002;32-39.
40. Mignery G.A., Newton C.L., Archer B.T., Sudhof T.C. Structure and expression of the rat inositol 1,4,5-trisphosphate receptor. J. Biol. Chem. 265:1990;12679-12685.
41. Nasir J., Goldberg Y.P., Hayden M.R. Huntington disease. new insights into the relationship between CAG expansion and disease Hum. Mol. Genet. 5:1996;1431-1435.
42. Nasir J., Duan K., Nichol K., Engelender S., Ashworth R., Colomer V., Thomas S., Disteche C.M., Hayden M.R., Ross C.A. Gene structure and map location of the murine homolog of the Huntington-associated protein, Hap1. Mamm. Genome. 9:1998;565-570.
43. Page K.J., Potter L., Aronni S., Everitt B.J., Dunnett S.B. The expression of Huntingtin-associated protein (HAP1) mRNA in developing, adult and ageing rat CNS. implications for Huntington's disease neuropathology Eur. J. Neurosci. 10:1998;1835-1845.
44. Panov A.V., Gutekunst C.A., Leavitt B.R., Hayden M.R., Burke J.R., Strittmatter W.J., Greenamyre J.T. Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines. Nat. Neurosci. 5:2002;731-736.
45. Pin J.P., Duvoisin R. The metabotropic glutamate receptors. structure and functions Neuropharmacology. 34:1995;1-26.
46. Pisani A., Gubellini P., Bonsi P., Conquet F., Picconi B., Centonze D., Bernardi G., Calabresi P. Metabotropic glutamate receptor 5 mediates the potentiation of N-methyl-D-aspartate responses in medium spiny striatal neurons. Neuroscience. 106:2001;579-587.
47. Rubinsztein D.C. Lessons from animal models of Huntington's disease. Trends Genet. 18:2002;202-209.
48. Sambrook, J., Fritsch, E.F., and Maniatis, T. (1989). Molecular Cloning: A Laboratory Manual, 2nd Edition (New York: Cold Spring Harbor Laboratory Press).
49. Schoepp D.D., Jane D.E., Monn J.A. Pharmacological agents acting at subtypes of metabotropic glutamate receptors. Neuropharmacology. 38:1999;1431-1476.
50. Singaraja R.R., Hadano S., Metzler M., Givan S., Wellington C.L., Warby S., Yanai A., Gutekunst C.A., Leavitt B.R., Yi H.et al. HIP14, a novel ankyrin domain-containing protein, links huntingtin to intracellular trafficking and endocytosis. Hum. Mol. Genet. 11:2002;2815-2828.
51. Skeberdis V.A., Lan J., Opitz T., Zheng X., Bennett M.V., Zukin R.S. mGluR1-mediated potentiation of NMDA receptors involves a rise in intracellular calcium and activation of protein kinase C. Neuropharmacology. 40:2001;856-865.
52. Street V.A., Bosma M.M., Demas V.P., Regan M.R., Lin D.D., Robinson L.C., Agnew W.S., Tempel B.L. The type 1 inositol 1,4,5-trisphosphate receptor gene is altered in the opisthotonos mouse. J. Neurosci. 17:1997;635-645.
53. Sun Y., Savanenin A., Reddy P.H., Liu Y.F. Polyglutamine-expanded huntingtin promotes sensitization of N-methyl-D-aspartate receptors via post-synaptic density 95. J. Biol. Chem. 276:2001;24713-24718.
54. Tallaksen-Greene S.J., Kaatz K.W., Romano C., Albin R.L. Localization of mGluR1a-like immunoreactivity and mGluR5-like immunoreactivity in identified populations of striatal neurons. Brain Res. 780:1998;210-217.
55. Tang T.S., Tu H., Wang Z., Bezprozvanny I. Modulation of type 1 inositol (1,4,5)-trisphosphate receptor function by protein kinase a and protein phosphatase 1alpha. J. Neurosci. 23:2003;403-415.
56. Tobin A.J., Signer E.R. Huntington's disease. the challenge for cell biologists Trends Cell Biol. 10:2000;531-536.
57. Tu H., Miyakawa T., Wang Z., Glouchankova L., Iino M., Bezprozvanny I. Functional characterization of the type 1 inositol 1,4,5-trisphosphate receptor coupling domain SII(+/-) splice variants and the opisthotonos mutant form. Biophys. J. 82:2002;1995-2004.
58. Vonsattel J.P., DiFiglia M. Huntington disease. J. Neuropathol. Exp. Neurol. 57:1998;369-384.
59. Vonsattel J.P., Myers R.H., Stevens T.J., Ferrante R.J., Bird E.D., Richardson E.P. Jr. Neuropathological classification of Huntington's disease. J. Neuropathol. Exp. Neurol. 44:1985;559-577.
60. Wellington C.L., Singaraja R., Ellerby L., Savill J., Roy S., Leavitt B., Cattaneo E., Hackam A., Sharp A., Thornberry N.et al. Inhibiting caspase cleavage of huntingtin reduces toxicity and aggregate formation in neuronal and nonneuronal cells. J. Biol. Chem. 275:2000;19831-19838.
61. Wellington C.L., Ellerby L.M., Gutekunst C.A., Rogers D., Warby S., Graham R.K., Loubser O., van Raamsdonk J., Singaraja R., Yang Y.Z.et al. Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington's disease. J. Neurosci. 22:2002;7862-7872.
62. Zeron M.M., Chen N., Moshaver A., Lee A.T., Wellington C.L., Hayden M.R., Raymond L.A. Mutant huntingtin enhances excitotoxic cell death. Mol. Cell. Neurosci. 17:2001;41-53.
63. Zeron M.M., Hansson O., Chen N., Wellington C.L., Leavitt B.R., Brundin P., Hayden M.R., Raymond L.A. Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease. Neuron. 33:2002;849-860.